Active sales and marketing efforts of GEMS™ WIN as a Windows 7 compatible ECG management software nets new license agreements from a wide array of customers

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that sales of its new Global ECG Management System release (GEMS™  WIN), a Windows 7 compatible version of the Company’s GEMS™ software technology, is gaining traction. CardioComm Solutions’ release of GEMS™ WIN is in response to the recent termination of Microsoft support for Windows XP as of April 2014. The GEMS™ WIN software release allows for functional operation of GEMS™ on the Windows 7 Operating System.

The Company recently confirmed completion of an organizational refocusing of resources on GEMS™ WIN inside sales and targeting their existing customer base of GEMS™ users. “Response from our customers has been extremely encouraging. With results based on just over two months of effort since the June release of GEMS™ WIN, the Company has already secured purchase orders as part of a sales funnel currently in excess of $300,000 in annual and recurrent licensing fees,” reported Simi Grosman, member of the Company’s Board of Directors. “Equally encouraging is the fact that the business is coming from a wide range of target groups including Independent Diagnostic Testing Facilities (IDTFs), Community Hospitals, Universities and Cardiology Centres.”

CardioComm Solutions has also initiated an international advertising effort to expand awareness of the availability of the Windows 7 compatible GEMS™ WIN software solution through HospiMedica, a medical publication that reaches 30,000 key hospital decision makers and medical equipment dealers/distributors in Europe, Latin America, the Middle East/Africa and Asia/Pacific.  CardioComm Solutions already boasts a client base that extends into 20 countries and the Company’s international distributors are expected to be able to leverage this publication to gain further traction within their target markets.

“The initial sales focus has been on our extensive customer base of current US and Canadian health care providers and customers,” noted Etienne Grima, CEO of CardioComm Solutions, Inc. “The easy-to-use GEMS™ XP based user interface has been maintained in the GEMS™ WIN upgrade. Providing our clients with the ability for continued normal operations with minimum downtime and no staff re-training and education during the upgrade process is a compelling proposition for our current users,” Grima added. The GEMS™ WIN system can track and store comprehensive patient information including enrollments, symptoms, medications, diagnoses, inventory, devices, follow-ups, schedules and a multitude of reporting options for a variety of patient follow-ups and tests. The GEMS™ WIN user-friendly patient management system is the easiest way to receive and store ECGs and patient information on the market today and is specifically designed to accommodate busy clinics and healthcare professionals with their daily tasks.

The Company intends to solidify its technology provider relationship with hundreds of cardiology-based clinical providers and monitoring services across Canada, the United States and internationally. CardioComm Solutions’ GEMS™ WIN release will soon offer its customers the use of new arrhythmia monitors with planned wireless capability to address currently underserved demands for a reliable and cost-effective solution, solutions that will open new sales opportunities where providing wireless devices for ambulatory arrhythmia monitoring presents a universal need.